Tijori
Anuh Pharma Limited
Market Capital
₹ 945 Cr.
P/E
37.56
  • Anuh Pharma Limited
  • Overview
  • Connections
  • Financials
  • Shareholding
  • Knowledge Base
  • Pharma Sector

  • Market Share
  • Revenue Mix
  • Operational Metrics

  • Competitors

  • Price
  • Benchmarking
  • Balance Sheet
  • Profit & Loss
  • Cash Flows
  • Ratios
  • Quarterly Results

  • Overview
  • Trend
  • Detailed

  • Recent News
  • Annual Reports

Market Share
33%
Pyrazinamide - Market Share
22%
Chloramphenicol - Market Share
18%
Erythromycin - Market Share
7%
Corticosteroids - Market Share
Revenue Mix
Product Break-Up
Location Wise Break-Up
Brandwise Break-Up
Operational Metrics for Anuh Pharma
-0.54% (as of Mar 19)
Change in PAT with 1% Appreciation in FX Basket
0.50% (as of Mar 19)
Management Compensation as a % of Sales
Pharmaceuticals
1.27% (as of Mar 18)
R&D as a % of Total Sales
Compare with Competitors


Competitors
Peer Name Market Cap.
Anuh Pharma Limited 945
Morepen Laboratories Limited 1,044
DIL Limited 1,063
Wendt (India) Limited 654
TTK Healthcare Limited 646
RPG Life Sciences Limited 644
Gufic Biosciences Limited 630
Suven Life Sciences Limited 623
Bajaj Healthcare Limited 606
Lincoln Pharmaceuticals Limited 508
Neuland Laboratories Limited 1,387
Nectar Lifesciences Limited 492
Medicamen Biotech Limited 490
Healthcare Global Enterprises Limited 1,404
Hester Biosciences Ltd 1,485
Zota Healthcare Limited 358
Novartis India Ltd 1,565
Themis Medicare Limited 294
Ind-Swift Laboratories Limited 266
Albert David Limited 237
Bharat Parenterals Limited 235
Vivimed Labs Limited 158
Unichem Laboratories Limited 1,743
Zim Laboratories Limited 146
Ambalal Sarabhai Enterprises Limited 136
Coral Lab 135
Dr Agarwals Eye Hospital Ltd. 107
Fredun Pharmaceuticals Limited 92
Bal Pharma Limited 62
Himalaya Food lnternational Ltd. 46
Ind-Swift Limited 22
Marksans Pharma Limited 1,944
Astec LifeSciences Limited 2,111
Hikal Limited 2,146
Claris Lifesciences Limited 2,164
Fresenius Kabi Oncology Ltd. 2,255
Dishman Carbogen Amics Limited 2,394
Indoco Remedies Limited 2,406
Alembic Limited 2,726
Wockhardt Limited 3,047
Advanced Enzyme Technologies Limited 3,271
Sequent Scientific Limited 3,630
Thyrocare Technologies Limited 4,026
Caplin Point Laboratories Limited 4,173
IOL Chemicals and Pharmaceuticals Limited 4,385
Sun Pharma Advanced Research Company Limited 4,402
Shilpa Medicare Limited 4,608
FDC Limited 5,711
Strides Pharma Science Limited 5,917
Narayana Hrudayalaya Ltd 6,496
Aarti Drugs Limited 6,879
Eris Lifesciences 7,344
Merck Limited 8,113
Granules India Limited 9,300
Fortis Healthcare Limited 10,362
Jubilant Life Sciences Limited 11,450
Ajanta Pharma Limited 13,535
Glenmark Pharmaceuticals Limited 13,623
Laurus Labs 14,226
Natco Pharma Limited 16,123
Aarti Industries Limited 17,521
Alembic Pharmaceuticals Limited 18,774
Sanofi India Limited 19,710
Pfizer Limited 22,500
BEL Limited 22,733
GlaxoSmithKline Pharmaceuticals Limited 26,158
IPCA Laboratories Limited 26,247
Piramal Enterprises Limited 28,092
Alkem Laboratories Limited 33,477
Abbott India Limited 34,438
Cadila Healthcare Limited 39,476
Lupin Limited 45,224
Aurobindo Pharma Limited 45,229
Torrent Pharmaceuticals Limited 46,008
Biocon Limited 51,348
Cipla Limited 62,104
Divi's Laboratories Limited 81,272
Dr. Reddy's Laboratories Limited 85,031
Sun Pharmaceuticals Industries Limited 117,435
Show More
Benchmarking
2035
Balance Sheet
  • Standalone
  • Consolidated
  • View Detailed
(in Rs. Cr.) Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
View previous years
View fewer years
Profit & Loss
  • Standalone
  • Consolidated
  • View Detailed
(in Rs. Cr.) Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
View previous years
View fewer years
Cash Flow
  • Standalone
  • Consolidated
(in Rs. Cr.) Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
View previous years
View fewer years
Ratios
= Dominant Factor
(in Rs. Cr.) Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
View previous years
View fewer years
Quarterly Results
  • Standalone
  • Consolidated
(in Rs. Cr.) Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020
View previous years
View fewer years
Overview
Shareholder Break-up
Trend
  • 1y
  • 2y
  • 4y
  • 5y
  • 10y
    Promoter
    Mutual Funds
    Insurance Companies
    FII
    DII Others
    Others
    Shares Pledged by Promoters(As a % of Total Promoter Holding)
Share this custom chart